Cargando…
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
BACKGROUND & AIMS: Liver resection (LR) in patients with hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) defined as a hepatic venous pressure gradient (HVPG) ≥10 mmHg is not encouraged. Here, we reappraised the outcomes of patients with cirrhosis and CSPH who...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689549/ https://www.ncbi.nlm.nih.gov/pubmed/33294830 http://dx.doi.org/10.1016/j.jhepr.2020.100190 |
_version_ | 1783613884817473536 |
---|---|
author | Azoulay, Daniel Ramos, Emilio Casellas-Robert, Margarida Salloum, Chady Lladó, Laura Nadler, Roy Busquets, Juli Caula-Freixa, Celia Mils, Kristel Lopez-Ben, Santiago Figueras, Joan Lim, Chetana |
author_facet | Azoulay, Daniel Ramos, Emilio Casellas-Robert, Margarida Salloum, Chady Lladó, Laura Nadler, Roy Busquets, Juli Caula-Freixa, Celia Mils, Kristel Lopez-Ben, Santiago Figueras, Joan Lim, Chetana |
author_sort | Azoulay, Daniel |
collection | PubMed |
description | BACKGROUND & AIMS: Liver resection (LR) in patients with hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) defined as a hepatic venous pressure gradient (HVPG) ≥10 mmHg is not encouraged. Here, we reappraised the outcomes of patients with cirrhosis and CSPH who underwent LR for HCC in highly specialised liver centres. METHODS: This was a retrospective multicentre study from 1999 to 2019. Predictors for postoperative liver decompensation and textbook outcomes were identified. RESULTS: In total, 79 patients with a median age of 65 years were included. The Child-Pugh grade was A in 99% of patients, and the median model for end-stage liver disease (MELD) score was 8. The median HVPG was 12 mmHg. Major hepatectomies and laparoscopies were performed in 28% and 34% of patients, respectively. Ninety-day mortality and severe morbidity rates were 6% and 27%, respectively. Postoperative and persistent liver decompensation occurred in 35% and 10% of patients at 3 months. Predictors of liver decompensation included increased preoperative HVPG (p = 0.004), increased serum total bilirubin (p = 0.02), and open approach (p = 0.03). Of the patients, 34% achieved a textbook outcome, of which the laparoscopic approach was the sole predictor (p = 0.004). The 5-year overall survival and recurrence-free survival rates were 55% and 43%, respectively. CONCLUSIONS: Patients with cirrhosis, HCC and HVPG ≥10 mmHg can undergo LR with acceptable mortality, morbidity, and liver decompensation rates. The laparoscopic approach was the sole predictor of a textbook outcome. LAY SUMMARY: Patients with cirrhosis, hepatocellular carcinoma, and clinically significant portal hypertension (defined as a hepatic venous pressure gradient ≥10 mmHg) can undergo resection with acceptable mortality, morbidity, liver decompensation rates, and a textbook outcome. These results can be achieved in selected patients with preserved liver function, good general status, and sufficient remnant liver volume. |
format | Online Article Text |
id | pubmed-7689549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-76895492020-12-07 Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension Azoulay, Daniel Ramos, Emilio Casellas-Robert, Margarida Salloum, Chady Lladó, Laura Nadler, Roy Busquets, Juli Caula-Freixa, Celia Mils, Kristel Lopez-Ben, Santiago Figueras, Joan Lim, Chetana JHEP Rep Research Article BACKGROUND & AIMS: Liver resection (LR) in patients with hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) defined as a hepatic venous pressure gradient (HVPG) ≥10 mmHg is not encouraged. Here, we reappraised the outcomes of patients with cirrhosis and CSPH who underwent LR for HCC in highly specialised liver centres. METHODS: This was a retrospective multicentre study from 1999 to 2019. Predictors for postoperative liver decompensation and textbook outcomes were identified. RESULTS: In total, 79 patients with a median age of 65 years were included. The Child-Pugh grade was A in 99% of patients, and the median model for end-stage liver disease (MELD) score was 8. The median HVPG was 12 mmHg. Major hepatectomies and laparoscopies were performed in 28% and 34% of patients, respectively. Ninety-day mortality and severe morbidity rates were 6% and 27%, respectively. Postoperative and persistent liver decompensation occurred in 35% and 10% of patients at 3 months. Predictors of liver decompensation included increased preoperative HVPG (p = 0.004), increased serum total bilirubin (p = 0.02), and open approach (p = 0.03). Of the patients, 34% achieved a textbook outcome, of which the laparoscopic approach was the sole predictor (p = 0.004). The 5-year overall survival and recurrence-free survival rates were 55% and 43%, respectively. CONCLUSIONS: Patients with cirrhosis, HCC and HVPG ≥10 mmHg can undergo LR with acceptable mortality, morbidity, and liver decompensation rates. The laparoscopic approach was the sole predictor of a textbook outcome. LAY SUMMARY: Patients with cirrhosis, hepatocellular carcinoma, and clinically significant portal hypertension (defined as a hepatic venous pressure gradient ≥10 mmHg) can undergo resection with acceptable mortality, morbidity, liver decompensation rates, and a textbook outcome. These results can be achieved in selected patients with preserved liver function, good general status, and sufficient remnant liver volume. Elsevier 2020-10-08 /pmc/articles/PMC7689549/ /pubmed/33294830 http://dx.doi.org/10.1016/j.jhepr.2020.100190 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Azoulay, Daniel Ramos, Emilio Casellas-Robert, Margarida Salloum, Chady Lladó, Laura Nadler, Roy Busquets, Juli Caula-Freixa, Celia Mils, Kristel Lopez-Ben, Santiago Figueras, Joan Lim, Chetana Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title | Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title_full | Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title_fullStr | Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title_full_unstemmed | Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title_short | Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
title_sort | liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689549/ https://www.ncbi.nlm.nih.gov/pubmed/33294830 http://dx.doi.org/10.1016/j.jhepr.2020.100190 |
work_keys_str_mv | AT azoulaydaniel liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT ramosemilio liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT casellasrobertmargarida liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT salloumchady liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT lladolaura liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT nadlerroy liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT busquetsjuli liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT caulafreixacelia liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT milskristel liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT lopezbensantiago liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT figuerasjoan liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension AT limchetana liverresectionforhepatocellularcarcinomainpatientswithclinicallysignificantportalhypertension |